查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1824488

2025年全球血液和血液成分市场报告

Blood And Blood Components Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年血液和血液成分市场规模将强劲成长，到2029年将达到528亿美元，复合年增长率为5.3%。预测期内的成长归因于慢性病发病率的上升、政府措施以及全血需求的不断增长。预测期内的主要趋势包括更重视与其他公司的合作、推出创新产品、更重视研发活动、使用以物联网为基础的产品来避免血液和血液成分的污染，以及重视输血管理。

未来五年5.3%的预测成长率，较我们先前对该市场的预测略有下降0.3%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国的重症监护，因为这会增加从义大利和丹麦进口的血浆分离器和冷沉淀物生产系统的成本，从而可能延误挽救生命的输血，并增加血库的成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

创伤和道路交通事故的增加推动了血液及血液成分市场的发展。出血等创伤会显着减少血液量，而人体无法快速补充血液容积。此外，道路交通事故会导致大量出血，需要立即抢救。在这种情况下，患者必须输血或输血成分。例如，澳洲政府机构交通事故委员会报告称，2023年维多利亚州共有295人丧生于道路交通事故中，比2022年增加了22.4%（死亡人数增加54人）。此外，还发生了261起致命事故，比前一年的239起增加了22起（9%）。疾病盛行率的上升以及道路交通事故和伤害的增加正在推动血液需求，并促进市场成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球血液和血液成分：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球血液和血液成分市场：增长率分析
  • 全球血液与血液成分市场表现：规模与成长，2019-2024
  • 全球血液及血液成分市场预测：2024-2029年及2034年规模及成长
  • 全球血液与血液成分：总目标市场（TAM）

第六章 市场细分

  • 全球血液和血液成分市场：按产品、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全血
  • 血液成分
  • 全球血液和血液成分市场：按血液组成、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 红血球
  • 血小板
  • 电浆
  • 白血球
  • 全球血液和血液成分市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 其他的
  • 全球血液及血液成分市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 贫血
  • 创伤与手术
  • 癌症治疗
  • 出血性疾病
  • 全球血液及血液成分市场：全血细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 捐献全血
  • 自体全血
  • 全球血液和血液成分市场：按血液成分（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 红血球（RBC）
  • 血小板
  • 电浆
  • 白血球（WBC）

第七章 区域和国家分析

  • 全球血液和血液成分市场：区域表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球血液及血液成分市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 血液与血液成分市场：竞争格局
  • 血液和血液成分市场：公司简介
    • American Red Cross Overview, Products and Services, Strategy and Financial Analysis
    • The Japanese Red Cross Society Overview, Products and Services, Strategy and Financial Analysis
    • Canadian Blood Services Overview, Products and Services, Strategy and Financial Analysis
    • Australian Red Cross Overview, Products and Services, Strategy and Financial Analysis
    • and Vitalant Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • SANQUIN BLOOD SUPPLY FOUNDATION
  • New York Blood Center
  • Blood Bank of Alaska
  • Blood Centers of America
  • Xinjiang Deyuan Bioengineering
  • Harbin Pacific Biopharmaceutical
  • Southern Shuanglin Bio-Pharmacy
  • Beijing Tiantan Biological Products
  • Shanghai RAAS Blood Products
  • China Biologic Products
  • Hualan Biological Engineering
  • Biotest AG
  • Lorne Laboratories UK
  • LMB Germany
  • Bio Products Laboratory Ltd

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年血液和血液成分市场：提供新机会的国家
  • 2029年血液及血液成分市场：细分领域带来新机会
  • 2029年血液与血液成分市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25504u

Blood and Blood Components refer to the various elements of blood, including red blood cells, white blood cells, platelets, and plasma, that are separated for medical applications. These components are utilized to address a range of conditions such as anemia, clotting disorders, and immune deficiencies. Each component is transfused according to the specific requirements of the patient for their recovery.

Key products in the blood and blood components market include whole blood and its various components. Whole blood, derived from standard blood donations, is employed in treating conditions such as excessive bleeding, exchange transfusions, and self-blood donation. Blood components, such as red blood cells, platelets, plasma, and white blood cells, find applications in treating anemia, trauma, surgery, cancer, and bleeding disorders. End-users in this market comprise hospitals, ambulatory surgical centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The blood and blood components market research report is one of a series of new reports from The Business Research Company that provides blood and blood components market statistics, including blood and blood components industry global market size, regional shares, competitors with a blood and blood components market share, detailed blood and blood components market segments, market trends and opportunities, and any further data you may need to thrive in the blood and blood components industry. This blood and blood components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood and blood components market size has grown steadily in recent years. It will grow from $41.36 billion in 2024 to $43 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to increasing incidence of trauma and road accidents, increased aging population, increased earnings and standard of living, increased healthcare expenditure, and rising awareness about blood donation.

The blood and blood components market size is expected to see strong growth in the next few years. It will grow to $52.8 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to an increase in chronic diseases, government initiatives, and increasing demand for whole blood. Major trends in the forecast period include focusing on collaboration with other players, launching innovative products, focusing on research and development (R&D) activities, using IoT-based products to avoid the contamination of blood and blood components, and focusing on the management of blood transfusion.

The forecast of 5.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. emergency care by increasing costs for plasma separation devices and cryoprecipitate production systems imported from Italy and Denmark, potentially delaying life-saving transfusions and raising blood bank costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The blood and blood components market is being propelled by the rising occurrence of trauma and road accidents. Traumas such as hemorrhage can significantly reduce blood volume, which the body cannot replace quickly enough. Moreover, road accidents result in substantial blood loss that requires immediate restoration. These circumstances necessitate the transfusion of blood and its components into patients. For example, in 2023, the Transport Accident Commission, an Australian government agency, reported that 295 people lost their lives on Victorian roads, representing a 22.4% increase (54 more fatalities) compared to 2022. Additionally, there were 261 fatal crashes, an increase of 22 (9%) from the 239 recorded the previous year. The rising prevalence of diseases and the growing number of road accidents and traumas are driving up the demand for blood, thereby fueling market growth.

The burgeoning prevalence of bleeding disorders is anticipated to further drive the expansion of the blood and blood components market. Bleeding disorders, encompassing conditions such as hemophilia, involve impaired blood clotting, leading to excessive or prolonged bleeding, even from minor injuries or spontaneously. Blood and its components play a pivotal role in treating these disorders by providing essential elements such as red blood cells, platelets, and clotting factors. These components can be transfused to supplement or replace deficient or dysfunctional elements in patients, thereby enhancing their clotting abilities and overall health. For instance, as per the Centers for Disease Control and Prevention (CDC) in July 2023, hemophilia A occurs in approximately one in 5,000 male births in the United States, with an estimated 400 babies born with hemophilia A each year. Moreover, the current estimate suggests that between 30,000 to 33,000 males are living with hemophilia in the United States. Hence, the rising incidence of bleeding disorders is a key driver fueling the growth of the blood and blood components market.

The prevailing trend in the blood and blood components market revolves around an increasing number of collaborations among industry players. Companies are opting for partnerships and collaborations to broaden their market reach, expand their customer base, and raise awareness within the industry. For instance, the American Red Cross partnered with HealthStream to introduce a new program targeting healthcare organizations. Additionally, the BloodCenter of Wisconsin collaborated with SysLogic Inc. to explore RFID technology's potential in enhancing patient safety during the collection and transfusion of blood products.

Key companies within the blood and blood component market are prioritizing the development of innovative technologies, notably an advanced precision blood typing process, aimed at averting complications during blood transfusion procedures. Precision blood typing involves a proprietary process employing cutting-edge techniques and technologies to accurately determine an individual's specific blood type, encompassing both blood group and subgroup, ensuring safe and precise blood or blood product transfusions. For instance, in April 2023, the San Diego Blood Bank, a US-based blood bank, launched its precision blood initiative. This initiative seeks to elevate the standard of care for blood transfusion patients by scaling the precision blood typing process. The program's overarching goal is to positively impact and potentially save lives by enhancing the standard of care for individuals requiring blood transfusions.

In October 2022, Pfizer, a leading U.S. pharmaceutical company, successfully acquired Global Blood Therapeutics for an undisclosed sum. This strategic acquisition enhances Pfizer's expertise in addressing sickle cell disease, aligning with the company's 30-year legacy. Global Blood Therapeutics, a U.S.-based developer specializing in treatments for blood diseases, particularly sickle cell disease, brings valuable assets to further bolster Pfizer's position in the field.

Major companies operating in the blood and blood components market include American Red Cross, The Japanese Red Cross Society, Canadian Blood Services, Australian Red Cross, and Vitalant, SANQUIN BLOOD SUPPLY FOUNDATION, New York Blood Center, Blood Bank of Alaska, Blood Centers of America, Xinjiang Deyuan Bioengineering, Harbin Pacific Biopharmaceutical, Southern Shuanglin Bio-Pharmacy, Beijing Tiantan Biological Products, Shanghai RAAS Blood Products, China Biologic Products, Hualan Biological Engineering, Biotest AG, Lorne Laboratories UK, LMB Germany, Bio Products Laboratory Ltd, Clinical Trials Laboratory Services (CTLS), Roche, Hemanext Inc, Kedrion Biopharma, KalVista Pharmaceuticals, Personal Genome, Cellphire, Inc., Immuno-Mycologics INC, CSL Behring, Nordson Corporation, Octapharma Canada Inc., Abbott Laboratories, Grifols, Nipro Medical Corporation, Becton, Dickinson and Company

North America was the largest region in the blood and blood components market in 2024. Western Europe was the second largest region in the global blood and blood components market analysis. The regions covered in the blood and blood components market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood and blood components market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The blood and blood components market consist of sales of red cells, platelets, plasms, cryoprecipitated AHF, and granulocytes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood And Blood Components Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood and blood components market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood and blood components ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood and blood components market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Whole Blood, Blood Components
  • 2) By Blood Components: Red Blood Cells, Platelets, Plasma, White Blood Cells
  • 3) By End-User: Hospitals, Ambulatory Surgical Centers, Others
  • 4) By Application: Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders
  • Subsegments:
  • 1) By Whole Blood: Donor Whole Blood; Autologous Whole Blood
  • 2) By Blood Components: Red Blood Cells (RBCs); Platelets; Plasma; White Blood Cells (WBCs)
  • Companies Mentioned: American Red Cross; The Japanese Red Cross Society; Canadian Blood Services; Australian Red Cross; and Vitalant; SANQUIN BLOOD SUPPLY FOUNDATION; New York Blood Center; Blood Bank of Alaska; Blood Centers of America; Xinjiang Deyuan Bioengineering; Harbin Pacific Biopharmaceutical; Southern Shuanglin Bio-Pharmacy; Beijing Tiantan Biological Products; Shanghai RAAS Blood Products; China Biologic Products; Hualan Biological Engineering; Biotest AG; Lorne Laboratories UK; LMB Germany; Bio Products Laboratory Ltd; Clinical Trials Laboratory Services (CTLS); Roche; Hemanext Inc; Kedrion Biopharma; KalVista Pharmaceuticals; Personal Genome; Cellphire, Inc.; Immuno-Mycologics INC; CSL Behring; Nordson Corporation; Octapharma Canada Inc.; Abbott Laboratories; Grifols; Nipro Medical Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood And Blood Components Market Characteristics

3. Blood And Blood Components Market Trends And Strategies

4. Blood And Blood Components Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Blood And Blood Components Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Blood And Blood Components PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Blood And Blood Components Market Growth Rate Analysis
  • 5.4. Global Blood And Blood Components Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Blood And Blood Components Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Blood And Blood Components Total Addressable Market (TAM)

6. Blood And Blood Components Market Segmentation

  • 6.1. Global Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Blood
  • Blood Components
  • 6.2. Global Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Red Blood Cells
  • Platelets
  • Plasma
  • White Blood Cells
  • 6.3. Global Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • 6.4. Global Blood And Blood Components Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anemia
  • Trauma and Surgery
  • Cancer Treatment
  • Bleeding Disorders
  • 6.5. Global Blood And Blood Components Market, Sub-Segmentation Of Whole Blood, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Donor Whole Blood
  • Autologous Whole Blood
  • 6.6. Global Blood And Blood Components Market, Sub-Segmentation Of Blood Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Red Blood Cells (RBCs)
  • Platelets
  • Plasma
  • White Blood Cells (WBCs)

7. Blood And Blood Components Market Regional And Country Analysis

  • 7.1. Global Blood And Blood Components Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Blood And Blood Components Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood And Blood Components Market

  • 8.1. Asia-Pacific Blood And Blood Components Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood And Blood Components Market

  • 9.1. China Blood And Blood Components Market Overview
  • 9.2. China Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood And Blood Components Market

  • 10.1. India Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood And Blood Components Market

  • 11.1. Japan Blood And Blood Components Market Overview
  • 11.2. Japan Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood And Blood Components Market

  • 12.1. Australia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood And Blood Components Market

  • 13.1. Indonesia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood And Blood Components Market

  • 14.1. South Korea Blood And Blood Components Market Overview
  • 14.2. South Korea Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood And Blood Components Market

  • 15.1. Western Europe Blood And Blood Components Market Overview
  • 15.2. Western Europe Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood And Blood Components Market

  • 16.1. UK Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood And Blood Components Market

  • 17.1. Germany Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood And Blood Components Market

  • 18.1. France Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood And Blood Components Market

  • 19.1. Italy Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood And Blood Components Market

  • 20.1. Spain Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood And Blood Components Market

  • 21.1. Eastern Europe Blood And Blood Components Market Overview
  • 21.2. Eastern Europe Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood And Blood Components Market

  • 22.1. Russia Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood And Blood Components Market

  • 23.1. North America Blood And Blood Components Market Overview
  • 23.2. North America Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood And Blood Components Market

  • 24.1. USA Blood And Blood Components Market Overview
  • 24.2. USA Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood And Blood Components Market

  • 25.1. Canada Blood And Blood Components Market Overview
  • 25.2. Canada Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood And Blood Components Market

  • 26.1. South America Blood And Blood Components Market Overview
  • 26.2. South America Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood And Blood Components Market

  • 27.1. Brazil Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood And Blood Components Market

  • 28.1. Middle East Blood And Blood Components Market Overview
  • 28.2. Middle East Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood And Blood Components Market

  • 29.1. Africa Blood And Blood Components Market Overview
  • 29.2. Africa Blood And Blood Components Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Blood And Blood Components Market, Segmentation By Blood Components, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Blood And Blood Components Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood And Blood Components Market Competitive Landscape And Company Profiles

  • 30.1. Blood And Blood Components Market Competitive Landscape
  • 30.2. Blood And Blood Components Market Company Profiles
    • 30.2.1. American Red Cross Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. The Japanese Red Cross Society Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Canadian Blood Services Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Australian Red Cross Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. and Vitalant Overview, Products and Services, Strategy and Financial Analysis

31. Blood And Blood Components Market Other Major And Innovative Companies

  • 31.1. SANQUIN BLOOD SUPPLY FOUNDATION
  • 31.2. New York Blood Center
  • 31.3. Blood Bank of Alaska
  • 31.4. Blood Centers of America
  • 31.5. Xinjiang Deyuan Bioengineering
  • 31.6. Harbin Pacific Biopharmaceutical
  • 31.7. Southern Shuanglin Bio-Pharmacy
  • 31.8. Beijing Tiantan Biological Products
  • 31.9. Shanghai RAAS Blood Products
  • 31.10. China Biologic Products
  • 31.11. Hualan Biological Engineering
  • 31.12. Biotest AG
  • 31.13. Lorne Laboratories UK
  • 31.14. LMB Germany
  • 31.15. Bio Products Laboratory Ltd

32. Global Blood And Blood Components Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood And Blood Components Market

34. Recent Developments In The Blood And Blood Components Market

35. Blood And Blood Components Market High Potential Countries, Segments and Strategies

  • 35.1 Blood And Blood Components Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Blood And Blood Components Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Blood And Blood Components Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer